Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04992728 · ClinicalTrials.gov registry record
Prostate Assessment with Restriction Spectrum Imaging (RSI) MRI
A clinical trial of Prostate Cancer, sponsored by University of California, San Diego.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT04992728 is a study of Prostate Cancer that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 100 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04992728, a study of Prostate Cancer, is actively recruiting participants, sponsored by University of California, San Diego.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This single-center study will enroll 40 male participants to complete 2 diffusion magnetic resonance images within 30 days of each other.
Conditions Studied
Interventions
- OTHER Restricted Spectrum Magnetic Resonance Imagining
Study Locations (1)
California
- UCSD Moores Cancer Center - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-11-02 |
| Est. Completion | 2026-11-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04992728
The ClinicalTrials.gov registry entry for NCT04992728 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (84% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Restricted Spectrum Magnetic Resonance Imagining is the first listed.
NCT04992728 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04992728 about?
NCT04992728 is a clinical study titled "Prostate Assessment with Restriction Spectrum Imaging (RSI) MRI". This single-center study will enroll 40 male participants to complete 2 diffusion magnetic resonance images within 30 days of each other.
What is the current status of trial NCT04992728?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2021-11-02. Estimated completion is 2026-11-01.
What conditions does trial NCT04992728 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT04992728?
The interventions under investigation include: Restricted Spectrum Magnetic Resonance Imagining (OTHER).
Who is sponsoring clinical trial NCT04992728?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04992728 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy
RECRUITING
-
Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer
RECRUITING · Phase 2
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.